CVS Health Corp (CVS)
100.45
-0.07 (-0.07%)
USD |
NYSE |
Oct 05, 16:00
100.95
+0.50 (+0.50%)
Pre-Market: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 131.87B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 22.79% |
| Valuation | |
| PE Ratio | 16.33 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.4336 |
| Price to Book Value | 1.754 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.55 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.7291 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 50.09% |
News
Headline
Wire
Time (ET)
PR Newswire
10/06 08:00
Globe Newswire
10/04 09:30
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 11/03/2022* | -- | Results | Q3 2022 | -- | 2.00 | -- | |
| 11/03/2022* | 08:00 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 08/03/2022 | -- | Results | Q2 2022 | 2.40 | 2.18 | 10.10% | |
| 08/03/2022 | 08:00 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 05/04/2022 | -- | Results | Q1 2022 | 2.22 | 2.15 | 3.49% | |
| 05/04/2022 | 08:00 EST | Earnings Call | Q1 2022 | -- | -- | -- | |
| 02/09/2022 | -- | Results | Q4 2021 | 1.98 | 1.88 | 5.37% | |
| 02/09/2022 | 08:00 EST | Earnings Call | Q4 2021 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients. |
| URL | https://www.cvshealth.com |
| Investor Relations URL | https://investors.cvshealth.com |
| HQ State/Province | Rhode Island |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Equity Style | Large Cap/Value |
| Next Earnings Release | Nov. 03, 2022 (est.) |
| Last Earnings Release | Aug. 03, 2022 |
| Next Ex-Dividend Date | Oct. 20, 2022 |
| Last Ex-Dividend Date | Jul. 21, 2022 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 2.10 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 1.457 |
| Yield to Sector | 1.160 |
| Yield to Industry | 1.976 |
| Last Dividend Amt. | 0.55 |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | Jul. 21, 2022 |
| Yield (TTM) | 2.14% |
| Forward Yield | 2.19% |
| Payout Ratio | 34.05% |
| Cash Payout Ratio | 17.53% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of October 05, 2022.
Fundamentals
| Revenue (TTM) | 307.86B |
| Total Expenses (TTM) | 292.72B |
| Net Income (TTM) | 8.167B |
| Total Assets (Quarterly) | 230.28B |
| Total Liabilities (Quarterly) | 154.77B |
| Shareholders Equity (Quarterly) | 75.18B |
| Cash from Operations (TTM) | 18.53B |
| Cash from Investing (TTM) | -6.41B |
| Cash from Financing (TTM) | -9.955B |
Ratings
Profile
Edit
| Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients. |
| URL | https://www.cvshealth.com |
| Investor Relations URL | https://investors.cvshealth.com |
| HQ State/Province | Rhode Island |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Equity Style | Large Cap/Value |
| Next Earnings Release | Nov. 03, 2022 (est.) |
| Last Earnings Release | Aug. 03, 2022 |
| Next Ex-Dividend Date | Oct. 20, 2022 |
| Last Ex-Dividend Date | Jul. 21, 2022 |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| IHF | 229.26M USD | 14.81% |
| XLV | 1.036B USD | 2.77% |
| VHCIX | 436.99M USD | 2.35% |
| VHT | 436.99M USD | 2.35% |
| LCEYX | 281.68M USD | 2.32% |
| CWMFX | 2.979B USD | 2.04% |
| COWZ | 151.41M USD | 2.04% |
| OIEFX | 819.10M USD | 1.69% |
| JLGZX | 516.83M USD | 1.47% |
| CLBFX | 2.068B USD | 1.07% |
| IVE | 174.92M USD | 0.81% |
| IWD | 365.44M USD | 0.75% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| CVS Tweets |